About the company
Visma is a leading provider of mission-critical enterprise resource planning, accounting, payroll and transaction process outsourcing software to small and medium-sized businesses and to the public sector in Northern Europe.
The investment rationale
Hg saw an opportunity to invest in a company with strong year-on-year growth underpinned by the ongoing shift towards greater digitalisation and process automation, a succession of new customer wins and scale built through over 80 add-on acquisitions.
Software is a core sector for Hg and the manager has deep knowledge of both the sector and the company, having owned Visma across its funds over the past decade.
Our relationship
Pantheon has a long-standing relationship with Hg, having made primary commitments to its funds since 2006. PIP co-invested in three other transactions alongside Hg.
About the company
KD Pharma Group is a leading global producer of Omega-3 ingredients focused on highly purified Omega-3 fatty acids for pharmaceutical and nutraceutical products.
Investment rationale
KD Pharma Group is a market-leading business with key competitive advantages based on patented technology and processes. The company has an integrated supply chain that facilitates margin benefits, a strong repeat client base, and a strong brand based upon being a reliable and consistent producer of high-quality Active Pharmaceutical Ingredients (APIs).
KD Pharma has grown from a single-digit revenue business to one of the industry’s largest players.
Our relationship
PIP’s long-standing relationship with German mid-market buyout firm capiton, which started with a series of primary investments, has enabled PIP to participate in this attractive investment opportunity.
About the company
Juice Plus is a direct seller of whole food-based nutritional products including fruit and vegetable capsules and nutritional shakes.
By investing in Juice Plus alongside Altamont Capital Partners, PIP intends to capitalise on consumer lifestyle changes driven by healthy eating trends.
About the company
MediFox is a leading provider of software solutions to over 6,000 ambulatory care services, elderly care homes and therapists in Germany. Key services include resource and route planning, care documentation, as well as billing and administration services.
We invested in Medifox alongside Hg Capital to gain exposure to a recurring revenue business that is able to respond to demographic trends in Germany, such as the shift to outpatient care and efforts to increase productivity in healthcare.